Changeflow GovPing Telecom & Technology Machine Learning Predicts Gene Sequence Effects...
Routine Notice Added Final

Machine Learning Predicts Gene Sequence Effects on Endophenotypes

Favicon for changeflow.com USPTO Patent Applications - AI & Computing (G06N)
Published
Detected
Email

Summary

USPTO published patent application US20260100241A1 by Inari Agriculture Technology, Inc. describing a machine-learning method for predicting how gene regulatory sequences affect endophenotypes. The method involves inputting gene regulatory sequences into a trained model to generate effect predictions and selecting sequences based on desired phenotypic profiles.

What changed

USPTO published patent application US20260100241A1 for a machine-learning method that predicts effects of gene regulatory sequences on endophenotypes. The method involves obtaining gene regulatory sequences, inputting them into a trained machine-learning model to generate effect predictions across multiple endophenotypes, and selecting regulatory sequences that achieve desired phenotypic profiles.

For researchers and companies in agricultural biotechnology, crop improvement, and genomic research, this published application establishes intellectual property that may constrain future development in machine-learning-assisted gene regulatory sequence design. Freedom-to-operate analyses should consider these claims when developing similar computational genomics methods.

What to do next

  1. Monitor for patent prosecution updates and final grant
  2. Review claims for freedom-to-operate analysis
  3. Assess potential licensing opportunities if operating in agricultural biotech

Archived snapshot

Apr 10, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

PREDICTING EFFECTS OF GENE REGULATORY SEQUENCES ON ENDOPHENOTYPES USING MACHINE LEARNING

Application US20260100241A1 Kind: A1 Apr 09, 2026

Assignee

Inari Agriculture Technology, Inc.

Inventors

Ross Everett ALTMAN, Karl Anton Grothe KREMLING

Abstract

A method for generating a gene regulatory sequence with a desired endophenotype profile includes obtaining a plurality of gene regulatory sequences and inputting the plurality of gene regulatory sequences into a machine-learning model trained to obtain a plurality of effect predictions corresponding to a plurality of endophenotypes. The method further includes selecting one or more desired endophenotypes based on the plurality of endophenotypes and selecting a gene regulatory sequence in accordance with the one or more desired endophenotypes.

CPC Classifications

G16B 5/20 G06N 20/00 G16B 20/50 G16B 40/20

Filing Date

2023-06-23

Application No.

18877673

View original document →

Get daily alerts for USPTO Patent Applications - AI & Computing (G06N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 9th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260100241A1

Who this affects

Applies to
Researchers Pharmaceutical companies Manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent application IP licensing Genomics research
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare

Get alerts for this source

We'll email you when USPTO Patent Applications - AI & Computing (G06N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!